VioQuest Pharmaceuticals, Inc.
VOQP
$0.00
$0.000.00%
| 06/30/2008 | 03/31/2008 | 12/31/2007 | 09/30/2007 | 06/30/2007 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -53.47% | -24.45% | -74.32% | 78.05% | 10.15% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -52.05% | -26.86% | -25.97% | 182.15% | 52.05% |
| Operating Income | 52.05% | 26.86% | 25.97% | -182.15% | -52.05% |
| Income Before Tax | 47.09% | -36.52% | -64.68% | -252.93% | -51.82% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 47.09% | -36.52% | -52.52% | -252.93% | -51.82% |
| Earnings from Discontinued Operations | -- | -- | 99.93% | 134.26% | 18.37% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 54.27% | -22.34% | -11.59% | -52.88% | -35.96% |
| EBIT | 52.05% | 26.86% | 25.97% | -182.15% | -52.05% |
| EBITDA | 52.12% | 26.89% | 25.99% | -182.23% | -52.07% |
| EPS Basic | 42.11% | -14.87% | -2.28% | -26.69% | -35.98% |
| Normalized Basic EPS | 58.82% | -28.18% | 2.92% | -192.43% | -51.80% |
| EPS Diluted | 42.11% | -14.87% | -2.28% | -26.69% | -35.98% |
| Normalized Diluted EPS | 58.82% | -28.18% | 2.92% | -192.43% | -51.80% |
| Average Basic Shares Outstanding | 28.52% | 6.51% | 9.11% | 20.68% | 0.00% |
| Average Diluted Shares Outstanding | 28.52% | 6.51% | 9.11% | 20.68% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
